Alport Connect 2024, the annual Alport syndrome patient and family meeting in US

Published on 26/04/2024

27-28 July 2024
Denver, CA

ENYO Pharma is sponsoring and will attend Alport Connect 2024 organized by the American Alport Syndrome Foundation (ASF), the Alport syndrome patient-led non-profit organization in the US.

ENYO Pharma will meet patients and their families to present its starting Phase 2 “ALPESTRIA-1” clinical study with Vonafexor in Alport syndrome patients.

https://alportsyndrome.org/for-patients/alport-connect/

Read next in 'Events'

• J.P. Morgan week and WuXi Global Forum 2025 in San Francisco
• J.P. Morgan week et WuXi Global Forum 2025 à San Francisco
• 4th Rare & Genetic Kidney Disease Drug Development Summit
• 4th Rare & Genetic Kidney Disease Drug Development Summit
• MOSAIC - Global NASH Trialist Forum 2024